Mathilde Panot Sparks Outcry with Controversial Rejection of ‘Octobre Rose’ Campaign

On October 9, 2026, Mathilde Panot, deputy from La France insoumise (LFI), ignited significant controversy by refusing to participate in the "Octobre Rose" breast cancer awareness campaign. In a video posted on social media, Panot denounced the campaign as "absolute cynicism" and "pink washing," accusing political opponents—including those from President Macron’s government, the right, and the far-right—of hypocrisy. She criticized multinational corporations for profit-driven actions harmful to women's health, highlighting the reintroduction of pesticides such as glyphosate produced by Monsanto and Syngenta, which she linked to environmental and political injustices in Palestinian and Lebanese territories.

Panot called for an "October of anger" instead of a superficial awareness campaign. She traced the origins of "Octobre Rose" to Imperial Chemical Industries (ICI), a company she claimed sold toxic products while benefiting from cancer drug sales, framing the campaign as a marketing tool rather than genuine activism. Her rhetoric connected cancer to broader political issues, citing multinationals' influence and alleged complicity in colonial expansion through subsidiaries like Adama.

The political establishment reacted sharply. Health Minister Stéphanie Rist criticized Panot’s remarks as politically motivated and scientifically inaccurate, while Minister for Gender Equality Aurore Bergé questioned her shame. Former Health Minister Aurélien Rousseau called her comments "indecent." Marine Le Pen condemned Panot, accusing her of veiled anti-Semitism linked to her criticism of Israel-related companies. Social media responses ranged from accusations of exploiting a health crisis for political gain to shame over rejecting a unifying campaign symbol.

The debate underscores tensions in France's political discourse around health activism and corporate responsibility, illustrating how a public health campaign can become a flashpoint for broader ideological conflicts.